Table of Content

1 Sustained and Controlled Release Formulations Market Overview
1.1 Product Overview and Scope of Sustained and Controlled Release Formulations
1.2 Sustained and Controlled Release Formulations Segment by Type
1.2.1 Global Sustained and Controlled Release Formulations Market Value Comparison by Type (2024-2034)
1.2.2 Generic Drug
1.2.3 Original Drug
1.3 Sustained and Controlled Release Formulations Segment by Application
1.3.1 Global Sustained and Controlled Release Formulations Market Value by Application: (2024-2034)
1.3.2 Cardiovascular System Drugs
1.3.3 Nervous System Drugs
1.3.4 Digestive System and Metabolism
1.3.5 Other
1.4 Global Sustained and Controlled Release Formulations Market Size Estimates and Forecasts
1.4.1 Global Sustained and Controlled Release Formulations Revenue 2018-2029
1.4.2 Global Sustained and Controlled Release Formulations Sales 2018-2029
1.4.3 Global Sustained and Controlled Release Formulations Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Sustained and Controlled Release Formulations Market Competition by Manufacturers
2.1 Global Sustained and Controlled Release Formulations Sales Market Share by Manufacturers (2018-2024)
2.2 Global Sustained and Controlled Release Formulations Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Sustained and Controlled Release Formulations Average Price by Manufacturers (2018-2024)
2.4 Global Sustained and Controlled Release Formulations Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Sustained and Controlled Release Formulations, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sustained and Controlled Release Formulations, Product Type & Application
2.7 Sustained and Controlled Release Formulations Market Competitive Situation and Trends
2.7.1 Sustained and Controlled Release Formulations Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Sustained and Controlled Release Formulations Players Market Share by Revenue
2.7.3 Global Sustained and Controlled Release Formulations Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Sustained and Controlled Release Formulations Retrospective Market Scenario by Region
3.1 Global Sustained and Controlled Release Formulations Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Sustained and Controlled Release Formulations Global Sustained and Controlled Release Formulations Sales by Region: 2018-2029
3.2.1 Global Sustained and Controlled Release Formulations Sales by Region: 2018-2024
3.2.2 Global Sustained and Controlled Release Formulations Sales by Region: 2024-2029
3.3 Global Sustained and Controlled Release Formulations Global Sustained and Controlled Release Formulations Revenue by Region: 2018-2029
3.3.1 Global Sustained and Controlled Release Formulations Revenue by Region: 2018-2024
3.3.2 Global Sustained and Controlled Release Formulations Revenue by Region: 2024-2029
3.4 North America Sustained and Controlled Release Formulations Market Facts & Figures by Country
3.4.1 North America Sustained and Controlled Release Formulations Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Sustained and Controlled Release Formulations Sales by Country (2018-2029)
3.4.3 North America Sustained and Controlled Release Formulations Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Sustained and Controlled Release Formulations Market Facts & Figures by Country
3.5.1 Europe Sustained and Controlled Release Formulations Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Sustained and Controlled Release Formulations Sales by Country (2018-2029)
3.5.3 Europe Sustained and Controlled Release Formulations Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sustained and Controlled Release Formulations Market Facts & Figures by Country
3.6.1 Asia Pacific Sustained and Controlled Release Formulations Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Sustained and Controlled Release Formulations Sales by Country (2018-2029)
3.6.3 Asia Pacific Sustained and Controlled Release Formulations Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Sustained and Controlled Release Formulations Market Facts & Figures by Country
3.7.1 Latin America Sustained and Controlled Release Formulations Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Sustained and Controlled Release Formulations Sales by Country (2018-2029)
3.7.3 Latin America Sustained and Controlled Release Formulations Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sustained and Controlled Release Formulations Market Facts & Figures by Country
3.8.1 Middle East and Africa Sustained and Controlled Release Formulations Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Sustained and Controlled Release Formulations Sales by Country (2018-2029)
3.8.3 Middle East and Africa Sustained and Controlled Release Formulations Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sustained and Controlled Release Formulations Sales by Type (2018-2029)
4.1.1 Global Sustained and Controlled Release Formulations Sales by Type (2018-2024)
4.1.2 Global Sustained and Controlled Release Formulations Sales by Type (2024-2029)
4.1.3 Global Sustained and Controlled Release Formulations Sales Market Share by Type (2018-2029)
4.2 Global Sustained and Controlled Release Formulations Revenue by Type (2018-2029)
4.2.1 Global Sustained and Controlled Release Formulations Revenue by Type (2018-2024)
4.2.2 Global Sustained and Controlled Release Formulations Revenue by Type (2024-2029)
4.2.3 Global Sustained and Controlled Release Formulations Revenue Market Share by Type (2018-2029)
4.3 Global Sustained and Controlled Release Formulations Price by Type (2018-2029)
5 Segment by Application
5.1 Global Sustained and Controlled Release Formulations Sales by Application (2018-2029)
5.1.1 Global Sustained and Controlled Release Formulations Sales by Application (2018-2024)
5.1.2 Global Sustained and Controlled Release Formulations Sales by Application (2024-2029)
5.1.3 Global Sustained and Controlled Release Formulations Sales Market Share by Application (2018-2029)
5.2 Global Sustained and Controlled Release Formulations Revenue by Application (2018-2029)
5.2.1 Global Sustained and Controlled Release Formulations Revenue by Application (2018-2024)
5.2.2 Global Sustained and Controlled Release Formulations Revenue by Application (2024-2029)
5.2.3 Global Sustained and Controlled Release Formulations Revenue Market Share by Application (2018-2029)
5.3 Global Sustained and Controlled Release Formulations Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Humanwell Healthcare Co.,Ltd.
6.1.1 Humanwell Healthcare Co.,Ltd. Corporation Information
6.1.2 Humanwell Healthcare Co.,Ltd. Description and Business Overview
6.1.3 Humanwell Healthcare Co.,Ltd. Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Humanwell Healthcare Co.,Ltd. Sustained and Controlled Release Formulations Product Portfolio
6.1.5 Humanwell Healthcare Co.,Ltd. Recent Developments/Updates
6.2 Nanjing Yiheng Pharmaceutical Co., Ltd.
6.2.1 Nanjing Yiheng Pharmaceutical Co., Ltd. Corporation Information
6.2.2 Nanjing Yiheng Pharmaceutical Co., Ltd. Description and Business Overview
6.2.3 Nanjing Yiheng Pharmaceutical Co., Ltd. Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Nanjing Yiheng Pharmaceutical Co., Ltd. Sustained and Controlled Release Formulations Product Portfolio
6.2.5 Nanjing Yiheng Pharmaceutical Co., Ltd. Recent Developments/Updates
6.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd.
6.3.1 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Corporation Information
6.3.2 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Description and Business Overview
6.3.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Sustained and Controlled Release Formulations Product Portfolio
6.3.5 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Recent Developments/Updates
6.4 Qilu Pharmaceutical Co Ltd
6.4.1 Qilu Pharmaceutical Co Ltd Corporation Information
6.4.2 Qilu Pharmaceutical Co Ltd Description and Business Overview
6.4.3 Qilu Pharmaceutical Co Ltd Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Qilu Pharmaceutical Co Ltd Sustained and Controlled Release Formulations Product Portfolio
6.4.5 Qilu Pharmaceutical Co Ltd Recent Developments/Updates
6.5 Shanghai Pharmaceuticals Holding Co.,Ltd.
6.5.1 Shanghai Pharmaceuticals Holding Co.,Ltd. Corporation Information
6.5.2 Shanghai Pharmaceuticals Holding Co.,Ltd. Description and Business Overview
6.5.3 Shanghai Pharmaceuticals Holding Co.,Ltd. Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Shanghai Pharmaceuticals Holding Co.,Ltd. Sustained and Controlled Release Formulations Product Portfolio
6.5.5 Shanghai Pharmaceuticals Holding Co.,Ltd. Recent Developments/Updates
6.6 Yangtze River Pharmaceutical (Group) Co., Ltd.
6.6.1 Yangtze River Pharmaceutical (Group) Co., Ltd. Corporation Information
6.6.2 Yangtze River Pharmaceutical (Group) Co., Ltd. Description and Business Overview
6.6.3 Yangtze River Pharmaceutical (Group) Co., Ltd. Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Yangtze River Pharmaceutical (Group) Co., Ltd. Sustained and Controlled Release Formulations Product Portfolio
6.6.5 Yangtze River Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
6.7 PKU HealthCare Corp.,Ltd.
6.6.1 PKU HealthCare Corp.,Ltd. Corporation Information
6.6.2 PKU HealthCare Corp.,Ltd. Description and Business Overview
6.6.3 PKU HealthCare Corp.,Ltd. Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
6.4.4 PKU HealthCare Corp.,Ltd. Sustained and Controlled Release Formulations Product Portfolio
6.7.5 PKU HealthCare Corp.,Ltd. Recent Developments/Updates
6.8 Overseas Pharmaceuticals, Ltd.
6.8.1 Overseas Pharmaceuticals, Ltd. Corporation Information
6.8.2 Overseas Pharmaceuticals, Ltd. Description and Business Overview
6.8.3 Overseas Pharmaceuticals, Ltd. Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Overseas Pharmaceuticals, Ltd. Sustained and Controlled Release Formulations Product Portfolio
6.8.5 Overseas Pharmaceuticals, Ltd. Recent Developments/Updates
6.9 Novast Laboratories (China), LTD.
6.9.1 Novast Laboratories (China), LTD. Corporation Information
6.9.2 Novast Laboratories (China), LTD. Description and Business Overview
6.9.3 Novast Laboratories (China), LTD. Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Novast Laboratories (China), LTD. Sustained and Controlled Release Formulations Product Portfolio
6.9.5 Novast Laboratories (China), LTD. Recent Developments/Updates
6.10 Catalent
6.10.1 Catalent Corporation Information
6.10.2 Catalent Description and Business Overview
6.10.3 Catalent Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Catalent Sustained and Controlled Release Formulations Product Portfolio
6.10.5 Catalent Recent Developments/Updates
6.11 AstraZeneca Plc
6.11.1 AstraZeneca Plc Corporation Information
6.11.2 AstraZeneca Plc Sustained and Controlled Release Formulations Description and Business Overview
6.11.3 AstraZeneca Plc Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
6.11.4 AstraZeneca Plc Sustained and Controlled Release Formulations Product Portfolio
6.11.5 AstraZeneca Plc Recent Developments/Updates
6.12 Oakwood Labs
6.12.1 Oakwood Labs Corporation Information
6.12.2 Oakwood Labs Sustained and Controlled Release Formulations Description and Business Overview
6.12.3 Oakwood Labs Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Oakwood Labs Sustained and Controlled Release Formulations Product Portfolio
6.12.5 Oakwood Labs Recent Developments/Updates
6.13 Ascendia Pharma
6.13.1 Ascendia Pharma Corporation Information
6.13.2 Ascendia Pharma Sustained and Controlled Release Formulations Description and Business Overview
6.13.3 Ascendia Pharma Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Ascendia Pharma Sustained and Controlled Release Formulations Product Portfolio
6.13.5 Ascendia Pharma Recent Developments/Updates
6.14 Colorcon
6.14.1 Colorcon Corporation Information
6.14.2 Colorcon Sustained and Controlled Release Formulations Description and Business Overview
6.14.3 Colorcon Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Colorcon Sustained and Controlled Release Formulations Product Portfolio
6.14.5 Colorcon Recent Developments/Updates
6.15 Pfizer Inc.
6.15.1 Pfizer Inc. Corporation Information
6.15.2 Pfizer Inc. Sustained and Controlled Release Formulations Description and Business Overview
6.15.3 Pfizer Inc. Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Pfizer Inc. Sustained and Controlled Release Formulations Product Portfolio
6.15.5 Pfizer Inc. Recent Developments/Updates
6.16 Mylan
6.16.1 Mylan Corporation Information
6.16.2 Mylan Sustained and Controlled Release Formulations Description and Business Overview
6.16.3 Mylan Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Mylan Sustained and Controlled Release Formulations Product Portfolio
6.16.5 Mylan Recent Developments/Updates
6.17 Sandoz
6.17.1 Sandoz Corporation Information
6.17.2 Sandoz Sustained and Controlled Release Formulations Description and Business Overview
6.17.3 Sandoz Sustained and Controlled Release Formulations Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Sandoz Sustained and Controlled Release Formulations Product Portfolio
6.17.5 Sandoz Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sustained and Controlled Release Formulations Industry Chain Analysis
7.2 Sustained and Controlled Release Formulations Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sustained and Controlled Release Formulations Production Mode & Process
7.4 Sustained and Controlled Release Formulations Sales and Marketing
7.4.1 Sustained and Controlled Release Formulations Sales Channels
7.4.2 Sustained and Controlled Release Formulations Distributors
7.5 Sustained and Controlled Release Formulations Customers
8 Sustained and Controlled Release Formulations Market Dynamics
8.1 Sustained and Controlled Release Formulations Industry Trends
8.2 Sustained and Controlled Release Formulations Market Drivers
8.3 Sustained and Controlled Release Formulations Market Challenges
8.4 Sustained and Controlled Release Formulations Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Sustained and Controlled Release Formulations Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Sustained and Controlled Release Formulations Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Sustained and Controlled Release Formulations Market Competitive Situation by Manufacturers in 2022
Table 4. Global Sustained and Controlled Release Formulations Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Sustained and Controlled Release Formulations Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Sustained and Controlled Release Formulations Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Sustained and Controlled Release Formulations Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Sustained and Controlled Release Formulations Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Sustained and Controlled Release Formulations, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Sustained and Controlled Release Formulations, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Sustained and Controlled Release Formulations, Product Type & Application
Table 12. Global Key Manufacturers of Sustained and Controlled Release Formulations, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Sustained and Controlled Release Formulations by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sustained and Controlled Release Formulations as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Sustained and Controlled Release Formulations Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Sustained and Controlled Release Formulations Sales by Region (2018-2024) & (K Units)
Table 18. Global Sustained and Controlled Release Formulations Sales Market Share by Region (2018-2024)
Table 19. Global Sustained and Controlled Release Formulations Sales by Region (2024-2029) & (K Units)
Table 20. Global Sustained and Controlled Release Formulations Sales Market Share by Region (2024-2029)
Table 21. Global Sustained and Controlled Release Formulations Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Sustained and Controlled Release Formulations Revenue Market Share by Region (2018-2024)
Table 23. Global Sustained and Controlled Release Formulations Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Sustained and Controlled Release Formulations Revenue Market Share by Region (2024-2029)
Table 25. North America Sustained and Controlled Release Formulations Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Sustained and Controlled Release Formulations Sales by Country (2018-2024) & (K Units)
Table 27. North America Sustained and Controlled Release Formulations Sales by Country (2024-2029) & (K Units)
Table 28. North America Sustained and Controlled Release Formulations Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Sustained and Controlled Release Formulations Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Sustained and Controlled Release Formulations Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Sustained and Controlled Release Formulations Sales by Country (2018-2024) & (K Units)
Table 32. Europe Sustained and Controlled Release Formulations Sales by Country (2024-2029) & (K Units)
Table 33. Europe Sustained and Controlled Release Formulations Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Sustained and Controlled Release Formulations Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Sustained and Controlled Release Formulations Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Sustained and Controlled Release Formulations Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Sustained and Controlled Release Formulations Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Sustained and Controlled Release Formulations Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Sustained and Controlled Release Formulations Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Sustained and Controlled Release Formulations Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Sustained and Controlled Release Formulations Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Sustained and Controlled Release Formulations Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Sustained and Controlled Release Formulations Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Sustained and Controlled Release Formulations Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Sustained and Controlled Release Formulations Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Sustained and Controlled Release Formulations Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Sustained and Controlled Release Formulations Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Sustained and Controlled Release Formulations Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Sustained and Controlled Release Formulations Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Sustained and Controlled Release Formulations Sales (K Units) by Type (2018-2024)
Table 51. Global Sustained and Controlled Release Formulations Sales (K Units) by Type (2024-2029)
Table 52. Global Sustained and Controlled Release Formulations Sales Market Share by Type (2018-2024)
Table 53. Global Sustained and Controlled Release Formulations Sales Market Share by Type (2024-2029)
Table 54. Global Sustained and Controlled Release Formulations Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Sustained and Controlled Release Formulations Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Sustained and Controlled Release Formulations Revenue Market Share by Type (2018-2024)
Table 57. Global Sustained and Controlled Release Formulations Revenue Market Share by Type (2024-2029)
Table 58. Global Sustained and Controlled Release Formulations Price (US$/Unit) by Type (2018-2024)
Table 59. Global Sustained and Controlled Release Formulations Price (US$/Unit) by Type (2024-2029)
Table 60. Global Sustained and Controlled Release Formulations Sales (K Units) by Application (2018-2024)
Table 61. Global Sustained and Controlled Release Formulations Sales (K Units) by Application (2024-2029)
Table 62. Global Sustained and Controlled Release Formulations Sales Market Share by Application (2018-2024)
Table 63. Global Sustained and Controlled Release Formulations Sales Market Share by Application (2024-2029)
Table 64. Global Sustained and Controlled Release Formulations Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Sustained and Controlled Release Formulations Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Sustained and Controlled Release Formulations Revenue Market Share by Application (2018-2024)
Table 67. Global Sustained and Controlled Release Formulations Revenue Market Share by Application (2024-2029)
Table 68. Global Sustained and Controlled Release Formulations Price (US$/Unit) by Application (2018-2024)
Table 69. Global Sustained and Controlled Release Formulations Price (US$/Unit) by Application (2024-2029)
Table 70. Humanwell Healthcare Co.,Ltd. Corporation Information
Table 71. Humanwell Healthcare Co.,Ltd. Description and Business Overview
Table 72. Humanwell Healthcare Co.,Ltd. Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Humanwell Healthcare Co.,Ltd. Sustained and Controlled Release Formulations Product
Table 74. Humanwell Healthcare Co.,Ltd. Recent Developments/Updates
Table 75. Nanjing Yiheng Pharmaceutical Co., Ltd. Corporation Information
Table 76. Nanjing Yiheng Pharmaceutical Co., Ltd. Description and Business Overview
Table 77. Nanjing Yiheng Pharmaceutical Co., Ltd. Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Nanjing Yiheng Pharmaceutical Co., Ltd. Sustained and Controlled Release Formulations Product
Table 79. Nanjing Yiheng Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 80. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Corporation Information
Table 81. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Description and Business Overview
Table 82. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Sustained and Controlled Release Formulations Product
Table 84. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Recent Developments/Updates
Table 85. Qilu Pharmaceutical Co Ltd Corporation Information
Table 86. Qilu Pharmaceutical Co Ltd Description and Business Overview
Table 87. Qilu Pharmaceutical Co Ltd Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Qilu Pharmaceutical Co Ltd Sustained and Controlled Release Formulations Product
Table 89. Qilu Pharmaceutical Co Ltd Recent Developments/Updates
Table 90. Shanghai Pharmaceuticals Holding Co.,Ltd. Corporation Information
Table 91. Shanghai Pharmaceuticals Holding Co.,Ltd. Description and Business Overview
Table 92. Shanghai Pharmaceuticals Holding Co.,Ltd. Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Shanghai Pharmaceuticals Holding Co.,Ltd. Sustained and Controlled Release Formulations Product
Table 94. Shanghai Pharmaceuticals Holding Co.,Ltd. Recent Developments/Updates
Table 95. Yangtze River Pharmaceutical (Group) Co., Ltd. Corporation Information
Table 96. Yangtze River Pharmaceutical (Group) Co., Ltd. Description and Business Overview
Table 97. Yangtze River Pharmaceutical (Group) Co., Ltd. Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Yangtze River Pharmaceutical (Group) Co., Ltd. Sustained and Controlled Release Formulations Product
Table 99. Yangtze River Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
Table 100. PKU HealthCare Corp.,Ltd. Corporation Information
Table 101. PKU HealthCare Corp.,Ltd. Description and Business Overview
Table 102. PKU HealthCare Corp.,Ltd. Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. PKU HealthCare Corp.,Ltd. Sustained and Controlled Release Formulations Product
Table 104. PKU HealthCare Corp.,Ltd. Recent Developments/Updates
Table 105. Overseas Pharmaceuticals, Ltd. Corporation Information
Table 106. Overseas Pharmaceuticals, Ltd. Description and Business Overview
Table 107. Overseas Pharmaceuticals, Ltd. Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Overseas Pharmaceuticals, Ltd. Sustained and Controlled Release Formulations Product
Table 109. Overseas Pharmaceuticals, Ltd. Recent Developments/Updates
Table 110. Novast Laboratories (China), LTD. Corporation Information
Table 111. Novast Laboratories (China), LTD. Description and Business Overview
Table 112. Novast Laboratories (China), LTD. Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Novast Laboratories (China), LTD. Sustained and Controlled Release Formulations Product
Table 114. Novast Laboratories (China), LTD. Recent Developments/Updates
Table 115. Catalent Corporation Information
Table 116. Catalent Description and Business Overview
Table 117. Catalent Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Catalent Sustained and Controlled Release Formulations Product
Table 119. Catalent Recent Developments/Updates
Table 120. AstraZeneca Plc Corporation Information
Table 121. AstraZeneca Plc Description and Business Overview
Table 122. AstraZeneca Plc Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. AstraZeneca Plc Sustained and Controlled Release Formulations Product
Table 124. AstraZeneca Plc Recent Developments/Updates
Table 125. Oakwood Labs Corporation Information
Table 126. Oakwood Labs Description and Business Overview
Table 127. Oakwood Labs Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Oakwood Labs Sustained and Controlled Release Formulations Product
Table 129. Oakwood Labs Recent Developments/Updates
Table 130. Ascendia Pharma Corporation Information
Table 131. Ascendia Pharma Description and Business Overview
Table 132. Ascendia Pharma Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Ascendia Pharma Sustained and Controlled Release Formulations Product
Table 134. Ascendia Pharma Recent Developments/Updates
Table 135. Colorcon Corporation Information
Table 136. Colorcon Description and Business Overview
Table 137. Colorcon Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Colorcon Sustained and Controlled Release Formulations Product
Table 139. Colorcon Recent Developments/Updates
Table 140. Pfizer Inc. Corporation Information
Table 141. Pfizer Inc. Description and Business Overview
Table 142. Pfizer Inc. Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Pfizer Inc. Sustained and Controlled Release Formulations Product
Table 144. Pfizer Inc. Recent Developments/Updates
Table 145. Mylan Corporation Information
Table 146. Mylan Description and Business Overview
Table 147. Mylan Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Mylan Sustained and Controlled Release Formulations Product
Table 149. Mylan Recent Developments/Updates
Table 150. Sandoz Corporation Information
Table 151. Sandoz Description and Business Overview
Table 152. Sandoz Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. Sandoz Sustained and Controlled Release Formulations Product
Table 154. Sandoz Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Sustained and Controlled Release Formulations Distributors List
Table 158. Sustained and Controlled Release Formulations Customers List
Table 159. Sustained and Controlled Release Formulations Market Trends
Table 160. Sustained and Controlled Release Formulations Market Drivers
Table 161. Sustained and Controlled Release Formulations Market Challenges
Table 162. Sustained and Controlled Release Formulations Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Sustained and Controlled Release Formulations
Figure 2. Global Sustained and Controlled Release Formulations Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Sustained and Controlled Release Formulations Market Share by Type in 2022 & 2029
Figure 4. Generic Drug Product Picture
Figure 5. Original Drug Product Picture
Figure 6. Global Sustained and Controlled Release Formulations Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Sustained and Controlled Release Formulations Market Share by Application in 2022 & 2029
Figure 8. Cardiovascular System Drugs
Figure 9. Nervous System Drugs
Figure 10. Digestive System and Metabolism
Figure 11. Other
Figure 12. Global Sustained and Controlled Release Formulations Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Sustained and Controlled Release Formulations Market Size (2018-2029) & (US$ Million)
Figure 14. Global Sustained and Controlled Release Formulations Sales (2018-2029) & (K Units)
Figure 15. Global Sustained and Controlled Release Formulations Average Price (US$/Unit) & (2018-2029)
Figure 16. Sustained and Controlled Release Formulations Report Years Considered
Figure 17. Sustained and Controlled Release Formulations Sales Share by Manufacturers in 2022
Figure 18. Global Sustained and Controlled Release Formulations Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Sustained and Controlled Release Formulations Players: Market Share by Revenue in 2022
Figure 20. Sustained and Controlled Release Formulations Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Sustained and Controlled Release Formulations Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Sustained and Controlled Release Formulations Sales Market Share by Country (2018-2029)
Figure 23. North America Sustained and Controlled Release Formulations Revenue Market Share by Country (2018-2029)
Figure 24. United States Sustained and Controlled Release Formulations Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Sustained and Controlled Release Formulations Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Sustained and Controlled Release Formulations Sales Market Share by Country (2018-2029)
Figure 27. Europe Sustained and Controlled Release Formulations Revenue Market Share by Country (2018-2029)
Figure 28. Germany Sustained and Controlled Release Formulations Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Sustained and Controlled Release Formulations Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Sustained and Controlled Release Formulations Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Sustained and Controlled Release Formulations Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Sustained and Controlled Release Formulations Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Sustained and Controlled Release Formulations Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Sustained and Controlled Release Formulations Revenue Market Share by Region (2018-2029)
Figure 35. China Sustained and Controlled Release Formulations Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Sustained and Controlled Release Formulations Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Sustained and Controlled Release Formulations Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Sustained and Controlled Release Formulations Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Sustained and Controlled Release Formulations Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Sustained and Controlled Release Formulations Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Southeast Asia Sustained and Controlled Release Formulations Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Sustained and Controlled Release Formulations Sales Market Share by Country (2018-2029)
Figure 43. Latin America Sustained and Controlled Release Formulations Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Sustained and Controlled Release Formulations Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Sustained and Controlled Release Formulations Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Sustained and Controlled Release Formulations Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Sustained and Controlled Release Formulations Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Sustained and Controlled Release Formulations Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Sustained and Controlled Release Formulations Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Sustained and Controlled Release Formulations Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Sustained and Controlled Release Formulations Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Sustained and Controlled Release Formulations by Type (2018-2029)
Figure 53. Global Revenue Market Share of Sustained and Controlled Release Formulations by Type (2018-2029)
Figure 54. Global Sustained and Controlled Release Formulations Price (US$/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Sustained and Controlled Release Formulations by Application (2018-2029)
Figure 56. Global Revenue Market Share of Sustained and Controlled Release Formulations by Application (2018-2029)
Figure 57. Global Sustained and Controlled Release Formulations Price (US$/Unit) by Application (2018-2029)
Figure 58. Sustained and Controlled Release Formulations Value Chain
Figure 59. Sustained and Controlled Release Formulations Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed